Revise

Clinical trial transformation without turmoil. Formerly Rebar. Posts by founder Rahlyn Gossen. [email protected]

[Revise @revisetrials]

Clayton Christensen’s theory of disruptive innovation is the wrong inspiration for clinical trial innovators.

He had a far better, more useful framework.

https://t.co/87DWLPLbLt

[Revise @revisetrials]

@jlewisdc I think most people know the meaning of experimental, so yes that's an option. I think "possible treatment" communicates something similar as well. We've got to do better than investigational. That means nothing to the general public.

[Revise @revisetrials]

Some IRBs love the word "investigational," but is our industry really informing patients when using this word? We try to use phrasing that communicates the same thing but is not scientific jargon, but some IRBs just insist on using "investigational."

[Revise @revisetrials]

Happy Halloween! Here's a live look at Rebar HQ today 😜

[Revise @revisetrials]

If you ever invite me to a meeting like this, I assure you I will make it my top priority and clear my schedule if need be to be in attendance. #catpyjamajam

[Revise @revisetrials]

Excited to be attending an investigator’s meeting yesterday and today to discuss digital patient recruitment with research sites. Attended many of these as a study coordinator. #backtomyroots @LillyTrials

[Revise @revisetrials]

Ha, do I identify with this. An ongoing challenge for us while developing patient-friendly clinical trial content. https://t.co/cdGii44uQq

[Revise @revisetrials]

Thank you, @K8SB. #timesup for this kind of behavior. https://t.co/eOM6JaKdRd

[STAT @statnews]

Why diversity matters in clinical research. https://t.co/QIeT24Ehh2

[Revise @revisetrials]

In all the adverse event reporting training I've done over the years, gotta say I've never seen racism used as an event example in the training 😐https://t.co/Btzf3nXsCu

[Brian Stelter @brianstelter]

Roseanne has DELETED all of her posts about Ambien. But her earlier posts made Ambien the top trending topic on Twitter https://t.co/IOMCxOngo8

[Revise @revisetrials]

Good morning from the T3: Trials, Tech and Transformation conference in lovely Raleigh, NC! #T3Clinical

[Revise @revisetrials]

We're working on cool things to come with this website 🤓 https://t.co/KdMuWKihMo

[Matt Winslow @mattwinslow]

Great to see a client mentioned in @michaelpollan's latest @NYTHealth article regarding their work in depression clinical trials. See https://t.co/HBrLEscKRw for more!

[Revise @revisetrials]

When your "disruptive innovation" is actually just good old fashioned fraud https://t.co/zUMC5pP0WU

[Revise @revisetrials]

The @ConferenceForum Patients as Partners conference is Thursday in Philly. It's not too late to register! Use our code for 15% off: REB15 https://t.co/bFKLErIunv

[Revise @revisetrials]

@lanaasindy Yes, as you should! 👍 #teamoxfordcomma

[Susannah Fox @SusannahFox]

@RebarInter Thank you! Honored that you thought of me. Here's my collection of stories & studies about the power of community in health: https://t.co/egct0vgzD5

[Revise @revisetrials]

First person I thought of when I saw this article was @SusannahFox , who has long been preaching the power of community https://t.co/0hJOvmBh8u

[Brock Heinz @Brock_Heinz]

I love working with an organization that is aware that "patients are waiting". https://t.co/z5g60o171I

[Revise @revisetrials]

Thank you for dinner! It's always such a pleasure hanging out with the @HealthiVibe team and friends. https://t.co/xLa1R8lVDa

[Patient Experience Business Unit of CorEvitas, LLC @HealthiVibe]

We had a great time connecting with friends, colleagues, and clients this week at #SCOPE2018. Dinner at @CafeTuTuTango was unforgettable. Thank you for connecting over #clinicaltrials, #research and #patientcentricity.